Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia

• প্রধান লেখক: Mohammed Alqahtani (লেখক), Ahmed Al-jedai (লেখক), Albert Wertheimer (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: University of Minnesota Libraries Publishing, 2024-11-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Biosimilars are safe and effective treatments for chronic diseases such as cancer and rheumatoid arthritis. The Saudi Food and Drug Authority (SFDA) manages the quality and registration of biosimilars in the Kingdom of Saudi Arabia. However, disparities among regulatory authorities, such as the abse...